DESIREE NELSON: Open Payments
NPI 1992396915 · FARMINGTON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 41 payments from 19 companies in 2025. Trend: 2023 $1,539 · 2024 $976 · 2025 $907
Food & beverage: $808Education: $99
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $140 |
| INTUITIVE SURGICAL, INC. | 1 | $134 |
| Regeneron Healthcare Solutions, Inc. | 3 | $132 |
| Insmed, Inc. | 3 | $70 |
| GlaxoSmithKline, LLC. | 4 | $60 |
| Actelion Pharmaceuticals US, Inc. | 3 | $60 |
| Grifols USA, LLC | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Electromed, Inc. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
Products named: DUPIXENT, Da Vinci Surgical System, Arikayce, Prolastin-C Liquid, OPSUMIT, NUCALA, TEZSPIRE, SMARTVEST.
Industry payments across AR — which companies pay providers there.
